{"output": [["BioClin Therapeutics, Inc.", "COMP", "Has", "fibroblast growth factor receptor 3", "CONCEPT"], ["BioClin Therapeutics, Inc.", "COMP", "Develop", "B-701", "PRODUCT"], ["BioClin Therapeutics, Inc.", "COMP", "Operate_In", "Metastatic bladder cancer sector", "SECTOR"], ["BioClin Therapeutics, Inc.", "COMP", "Participates_In", "Clinical studies", "EVENT"], ["Graeme Currie", "PERSON", "Announce", "Appointment as Chief Operating Officer", "EVENT"], ["Graeme Currie", "PERSON", "Has", "Drug development experience", "CONCEPT"], ["Graeme Currie", "PERSON", "Work_In", "Pharmaceutical and biotechnology companies", "SECTOR"], ["Graeme Currie", "PERSON", "Hold", "Senior leadership roles", "CONCEPT"], ["Esteban (Steve) Abella", "PERSON", "Announce", "Appointment as Chief Medical Officer", "EVENT"], ["Esteban (Steve) Abella", "PERSON", "Active", "Cancer clinical trials research", "CONCEPT"], ["Esteban (Steve) Abella", "PERSON", "Work_In", "Gilead Sciences and Amgen", "COMP"], ["Stephen Lau", "PERSON", "Chief", "BioClin", "COMP"], ["B-701", "PRODUCT", "Top_Priority", "Developing and implementing clinical development strategy", "CONCEPT"], ["B-701", "PRODUCT", "Planning", "Registrational studies for metastatic bladder cancer", "EVENT"]], "published": "2018-01-09T16:00:00.000+02:00"}